nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—osteoarthritis	0.8	1	CbGaD
Pranlukast—Ospemifene—ESR1—osteoarthritis	0.00324	1	CrCbGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.000243	0.00124	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—TNF—osteoarthritis	0.000241	0.00123	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—MMP2—osteoarthritis	0.000241	0.00123	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—COL9A2—osteoarthritis	0.000238	0.00121	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—CXCL8—osteoarthritis	0.000237	0.0012	CbGpPWpGaD
Pranlukast—IL5—Immune System—CAMK2B—osteoarthritis	0.000235	0.0012	CbGpPWpGaD
Pranlukast—IL5—Immune System—CTSK—osteoarthritis	0.000235	0.0012	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—osteoarthritis	0.000234	0.00119	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000231	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—COL9A1—osteoarthritis	0.000231	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—TNF—osteoarthritis	0.00023	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—IL6—osteoarthritis	0.000227	0.00116	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—TNF—osteoarthritis	0.000227	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1RN—osteoarthritis	0.000227	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL1A—osteoarthritis	0.000226	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.000226	0.00115	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—osteoarthritis	0.00022	0.00112	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—IGF1—osteoarthritis	0.00022	0.00112	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—SMAD3—osteoarthritis	0.00022	0.00112	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—CXCL8—osteoarthritis	0.000216	0.0011	CbGpPWpGaD
Pranlukast—TNF—amb2 Integrin signaling—IL6—osteoarthritis	0.000215	0.00109	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000215	0.00109	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000214	0.00109	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—MMP1—osteoarthritis	0.000211	0.00107	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—IL1B—osteoarthritis	0.000211	0.00107	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL1B—osteoarthritis	0.000209	0.00106	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.000209	0.00106	CbGpPWpGaD
Pranlukast—NFKB1—TSLP Signaling Pathway—IL6—osteoarthritis	0.000208	0.00106	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL1B—osteoarthritis	0.000206	0.00105	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—TGFB1—osteoarthritis	0.000205	0.00104	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—LEP—osteoarthritis	0.000203	0.00103	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—CXCL8—osteoarthritis	0.0002	0.00102	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—CXCL8—osteoarthritis	0.000199	0.00101	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.000198	0.00101	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000197	0.000999	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TNF—osteoarthritis	0.000196	0.000997	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—IL6—osteoarthritis	0.000195	0.000989	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—COL9A2—osteoarthritis	0.000194	0.000988	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—CXCL8—osteoarthritis	0.000194	0.000988	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—FN1—osteoarthritis	0.000193	0.000981	CbGpPWpGaD
Pranlukast—TNF—IL23-mediated signaling events—IL6—osteoarthritis	0.000192	0.000974	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL1B—osteoarthritis	0.000191	0.00097	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IHH—osteoarthritis	0.00019	0.000966	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MCF2L—osteoarthritis	0.00019	0.000966	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—COL9A1—osteoarthritis	0.000189	0.000959	CbGpPWpGaD
Pranlukast—TNF—TGF-beta Receptor Signaling—TGFB1—osteoarthritis	0.000188	0.000955	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—LEP—osteoarthritis	0.000188	0.000955	CbGpPWpGaD
Pranlukast—IL5—Immune System—HSPA5—osteoarthritis	0.000187	0.000952	CbGpPWpGaD
Pranlukast—NFKB1—Signaling events mediated by HDAC Class I—TNF—osteoarthritis	0.000187	0.000951	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1A—osteoarthritis	0.000187	0.000951	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—CXCL8—osteoarthritis	0.000186	0.000945	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoarthritis	0.000186	0.000944	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.000185	0.000941	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL1B—osteoarthritis	0.000182	0.000927	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1RN—osteoarthritis	0.000182	0.000926	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—COL9A2—osteoarthritis	0.000181	0.00092	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—IL1B—osteoarthritis	0.000178	0.000907	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—IL1B—osteoarthritis	0.000178	0.000907	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000176	0.000894	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—COL9A1—osteoarthritis	0.000176	0.000893	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—TNF—osteoarthritis	0.000173	0.000881	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.000173	0.000881	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—IL6—osteoarthritis	0.000173	0.00088	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000173	0.00088	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL1A—osteoarthritis	0.000171	0.000869	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—IGF1—osteoarthritis	0.000169	0.000859	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CTSK—osteoarthritis	0.000164	0.000834	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—TGFB1—osteoarthritis	0.000164	0.000833	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000164	0.000832	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1A—osteoarthritis	0.000163	0.000829	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TNF—osteoarthritis	0.000162	0.000822	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.000162	0.000822	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—TGFB1—osteoarthritis	0.000161	0.000819	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—IL6—osteoarthritis	0.000158	0.000805	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CTSK—osteoarthritis	0.000158	0.000801	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—TNF—osteoarthritis	0.000156	0.000792	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—CXCL8—osteoarthritis	0.000155	0.000789	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IGF1—osteoarthritis	0.000155	0.000789	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—MMP3—osteoarthritis	0.000152	0.000771	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—CXCL8—osteoarthritis	0.000152	0.00077	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.000151	0.000769	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNF—osteoarthritis	0.00015	0.000765	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00015	0.000761	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.000149	0.000759	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL1B—osteoarthritis	0.000149	0.000757	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—IL6—osteoarthritis	0.000148	0.000754	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL1B—osteoarthritis	0.000145	0.000739	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.000143	0.000728	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—osteoarthritis	0.000143	0.000726	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.000142	0.00072	CbGpPWpGaD
Pranlukast—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoarthritis	0.000142	0.000719	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TGFB1—osteoarthritis	0.000141	0.000715	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—COL9A2—osteoarthritis	0.00014	0.000709	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—PTGS2—osteoarthritis	0.000139	0.000707	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—TGFB1—osteoarthritis	0.000139	0.000705	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TNF—osteoarthritis	0.000138	0.000704	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL1B—osteoarthritis	0.000137	0.000694	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.000136	0.000691	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—COL9A1—osteoarthritis	0.000135	0.000689	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CXCL8—osteoarthritis	0.000135	0.000686	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—IL6—osteoarthritis	0.000133	0.000676	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.000132	0.000671	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000132	0.00067	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1A—osteoarthritis	0.000131	0.000667	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL1B—osteoarthritis	0.000129	0.000658	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—BMP2—osteoarthritis	0.000129	0.000658	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 cascade initiated on plasma membrane—IL6—osteoarthritis	0.000129	0.000657	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoarthritis	0.000128	0.000651	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—IL1B—osteoarthritis	0.000128	0.000651	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 dependent cascade initiated on endosome—IL6—osteoarthritis	0.000126	0.000639	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—IL6—osteoarthritis	0.000126	0.000639	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HSPA5—osteoarthritis	0.000125	0.000638	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000124	0.000631	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—IL6—osteoarthritis	0.000124	0.000628	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CXCL8—osteoarthritis	0.000123	0.000625	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL6—osteoarthritis	0.000123	0.000623	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MMP9—osteoarthritis	0.000122	0.00062	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoarthritis	0.000121	0.000617	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—IL6—osteoarthritis	0.000121	0.000617	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL6—osteoarthritis	0.000121	0.000613	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoarthritis	0.000119	0.000606	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—osteoarthritis	0.000118	0.000601	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—IL6—osteoarthritis	0.000114	0.000582	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000114	0.00058	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL1B—osteoarthritis	0.000114	0.000577	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000113	0.000576	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL6—osteoarthritis	0.000112	0.000568	CbGpPWpGaD
Pranlukast—IL5—Immune System—CRP—osteoarthritis	0.00011	0.000557	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—osteoarthritis	0.000109	0.000555	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CXCL8—osteoarthritis	0.000109	0.000555	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—MMP3—osteoarthritis	0.000109	0.000554	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.000109	0.000553	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—osteoarthritis	0.000108	0.00055	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.000108	0.000548	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IHH—osteoarthritis	0.000108	0.000547	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MCF2L—osteoarthritis	0.000108	0.000547	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL6—osteoarthritis	0.000107	0.000543	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.000104	0.000526	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—IL6—osteoarthritis	0.000103	0.000523	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TGFB1—osteoarthritis	0.000101	0.000515	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TGFB1—osteoarthritis	0.000101	0.000511	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	9.98e-05	0.000507	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TGFB1—osteoarthritis	9.95e-05	0.000506	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—SMAD3—osteoarthritis	9.92e-05	0.000504	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—osteoarthritis	9.86e-05	0.000501	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	9.84e-05	0.0005	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1B—osteoarthritis	9.76e-05	0.000496	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoarthritis	9.68e-05	0.000492	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL6—osteoarthritis	9.58e-05	0.000487	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CAMK2B—osteoarthritis	9.56e-05	0.000486	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTSK—osteoarthritis	9.56e-05	0.000486	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	9.46e-05	0.000481	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—TGFB1—osteoarthritis	9.31e-05	0.000473	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CXCL8—osteoarthritis	9.3e-05	0.000473	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—osteoarthritis	9.29e-05	0.000472	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—BMP2—osteoarthritis	9.28e-05	0.000472	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—IL6—osteoarthritis	9.25e-05	0.00047	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	8.98e-05	0.000456	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP3—osteoarthritis	8.97e-05	0.000456	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	8.73e-05	0.000443	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—IL6—osteoarthritis	8.63e-05	0.000438	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CXCL8—osteoarthritis	8.59e-05	0.000437	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—osteoarthritis	8.52e-05	0.000433	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1B—osteoarthritis	8.51e-05	0.000432	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—LEP—osteoarthritis	8.48e-05	0.000431	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	8.38e-05	0.000426	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	8.25e-05	0.000419	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SMAD3—osteoarthritis	8.12e-05	0.000412	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—osteoarthritis	8e-05	0.000406	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—osteoarthritis	7.96e-05	0.000404	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—TGFB1—osteoarthritis	7.91e-05	0.000402	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—COL9A2—osteoarthritis	7.9e-05	0.000402	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCL8—osteoarthritis	7.8e-05	0.000397	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—COL9A1—osteoarthritis	7.67e-05	0.00039	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CRP—osteoarthritis	7.65e-05	0.000389	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HSPA5—osteoarthritis	7.61e-05	0.000387	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFB1—osteoarthritis	7.58e-05	0.000385	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—osteoarthritis	7.58e-05	0.000385	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—SMAD3—osteoarthritis	7.55e-05	0.000384	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1RN—osteoarthritis	7.4e-05	0.000376	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	7.19e-05	0.000366	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—osteoarthritis	7.01e-05	0.000356	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LEP—osteoarthritis	6.94e-05	0.000353	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—osteoarthritis	6.91e-05	0.000351	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	6.84e-05	0.000348	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1B—osteoarthritis	6.84e-05	0.000348	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP2—osteoarthritis	6.78e-05	0.000344	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	6.65e-05	0.000338	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ESR1—osteoarthritis	6.62e-05	0.000337	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FN1—osteoarthritis	6.54e-05	0.000332	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—LEP—osteoarthritis	6.46e-05	0.000328	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP3—osteoarthritis	6.44e-05	0.000327	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCL8—osteoarthritis	6.17e-05	0.000313	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—osteoarthritis	6.06e-05	0.000308	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SMAD3—osteoarthritis	5.82e-05	0.000296	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF1—osteoarthritis	5.73e-05	0.000291	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCL8—osteoarthritis	5.6e-05	0.000285	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1A—osteoarthritis	5.33e-05	0.000271	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—BMP2—osteoarthritis	5.26e-05	0.000267	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—osteoarthritis	5.22e-05	0.000265	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP2—osteoarthritis	5.16e-05	0.000262	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP9—osteoarthritis	5.09e-05	0.000259	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—osteoarthritis	4.98e-05	0.000253	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LEP—osteoarthritis	4.98e-05	0.000253	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—osteoarthritis	4.9e-05	0.000249	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ESR1—osteoarthritis	4.75e-05	0.000242	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FN1—osteoarthritis	4.69e-05	0.000239	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCL8—osteoarthritis	4.61e-05	0.000234	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—FMOD—osteoarthritis	4.51e-05	0.000229	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CRP—osteoarthritis	4.45e-05	0.000226	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—osteoarthritis	4.38e-05	0.000223	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TGFB1—osteoarthritis	4.2e-05	0.000213	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP9—osteoarthritis	4.17e-05	0.000212	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF1—osteoarthritis	4.11e-05	0.000209	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—osteoarthritis	4e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—osteoarthritis	3.92e-05	0.000199	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—osteoarthritis	3.88e-05	0.000197	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGES—osteoarthritis	3.67e-05	0.000187	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP3—osteoarthritis	3.64e-05	0.000185	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFB1—osteoarthritis	3.44e-05	0.000175	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL8—osteoarthritis	3.31e-05	0.000168	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SMAD3—osteoarthritis	3.3e-05	0.000168	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—osteoarthritis	3.2e-05	0.000163	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—osteoarthritis	3.16e-05	0.000161	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—osteoarthritis	3.15e-05	0.00016	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—osteoarthritis	2.99e-05	0.000152	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—FMOD—osteoarthritis	2.97e-05	0.000151	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LEP—osteoarthritis	2.82e-05	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—osteoarthritis	2.79e-05	0.000142	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—osteoarthritis	2.78e-05	0.000141	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ESR1—osteoarthritis	2.69e-05	0.000137	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FN1—osteoarthritis	2.66e-05	0.000135	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—osteoarthritis	2.59e-05	0.000132	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTO1—osteoarthritis	2.59e-05	0.000132	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—BGN—osteoarthritis	2.51e-05	0.000127	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—osteoarthritis	2.47e-05	0.000125	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGES—osteoarthritis	2.42e-05	0.000123	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—osteoarthritis	2.41e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1—osteoarthritis	2.33e-05	0.000118	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL8—osteoarthritis	1.87e-05	9.52e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—osteoarthritis	1.86e-05	9.45e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTO1—osteoarthritis	1.71e-05	8.68e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—osteoarthritis	1.69e-05	8.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—BGN—osteoarthritis	1.65e-05	8.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—osteoarthritis	1.63e-05	8.27e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.62e-05	8.23e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—osteoarthritis	1.4e-05	7.1e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—osteoarthritis	1.05e-05	5.35e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—osteoarthritis	7.21e-06	3.66e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—osteoarthritis	4.75e-06	2.42e-05	CbGpPWpGaD
